Use the Bayh-Dole Act to lower drug prices for government healthcare programs

Journal name:
Nature Medicine
Volume:
22,
Page:
576
Year published:
DOI:
doi:10.1038/nm0616-576
Published online

As drug prices have increased, there is also greater pressure to find ways to ensure access to medicines. An existing provision of the Bayh-Dole Act could help to lower costs for qualifying drugs in federal programs such as Medicare and Medicaid.

References

  1. Watanabe, T. UCLA will get hundreds of millions for rights to prostate cancer drug. LA Times (4 March 2016).
  2. http://bayhdolecentral.com/JoeAllen_part3/statment.on.s.414.pdf.
  3. 28 U.S.C. § 1498(a) (2015).
  4. Gore v. Garlock, 842 F.2d 1275, 1282 (Fed. Cir. 1988).

Download references

Author information

Affiliations

  1. Alfred B. Engelberg is a trustee at the Engelberg Foundation in Palm Beach, Florida, and

  2. Aaron S. Kesselheim is an associate professor of medicine at the Brigham and Women's Hospital and Harvard Medical School in Boston.

Author details

Additional data